<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-128620" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Nuclear Medicine SPECT Scan Cardiovascular Assessment, Protocols, and Interpretation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Adnan</surname>
            <given-names>Ghufran</given-names>
          </name>
          <aff>Aga Khan University Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rahman</surname>
            <given-names>Muhammad Nasir</given-names>
          </name>
          <aff>Aga Khan University Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ghufran Adnan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Nasir Rahman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-128620.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Myocardial perfusion scans are a widely used procedure to diagnose ischemic heart disease. This activity reviews the importance of these scans and highlights the role of the interprofessional team in performing them.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications for a myocardial perfusion scan</p></list-item><list-item><p>Assess&#x000a0;the technique of performing a myocardial perfusion scan.</p></list-item><list-item><p>Evaluate&#x000a0;the clinical significance of myocardial perfusion scan.</p></list-item><list-item><p>Communicate how an interprofessional team approach can improve patient outcomes when using myocardial perfusion scanning on appropriate patient populations.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=128620&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=128620">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-128620.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Myocardial perfusion single-photon emission computed tomography (MPS) is an important, cost-effective, and widely used non-invasive imaging modality. With the advancement in imaging techniques and for early detection of coronary artery disease, it is estimated that 9.1 million tests are performed annually in the United States.<xref ref-type="bibr" rid="article-128620.r1">[1]</xref>&#x000a0;Myocardial perfusion scan plays a crucial role in diagnosing ischemic coronary artery disease, predicting prognosis, and assessing myocardial viability and effectiveness of medical therapy.<xref ref-type="bibr" rid="article-128620.r2">[2]</xref>&#x000a0;The sensitivity of this test is improving continuously due to better technologies, new software, and radiotracers.<xref ref-type="bibr" rid="article-128620.r3">[3]</xref>&#x000a0;During a myocardial perfusion scan,&#x000a0; a gamma camera detects radiotracer injected intravenously to&#x000a0;measure the distribution of coronary blood flow in the myocardium. Multiple planar projections are collected by rotating the gamma camera at the regular angular interval in a 180-degree arc. Myocardial uptake of the tracer for the scan is dependent on&#x000a0;2 things. The first transportation of the radiotracer to the cell surface is flow-mediated. Second, the intact cell membrane is required to extract the radiotracer. The extraction of radiotracer is directly dependent on blood flow. The same phenomena that cause a reduction in oxygen delivery and ischemic ECG changes on a treadmill can be assessed by perfusion defect on MPS. However, reduced tracer uptake to specific regions helps diagnose the culprit artery responsible for patient symptoms. The difference in radiotracer uptake at rest and stress helps differentiate fixed and reversible defects.<xref ref-type="bibr" rid="article-128620.r4">[4]</xref></p>
      </sec>
      <sec id="article-128620.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>The myocardium is divided into 17 segments based on a short axis and a long axis slice. The short-axis view has a septal, anterior,&#x000a0; lateral, and inferior wall. On the long horizontal axis, there are septal walls and lateral walls. On a vertical long-axis view, there is an anterior and inferior wall.<xref ref-type="bibr" rid="article-128620.r4">[4]</xref>&#x000a0;The left anterior descending artery supplies the anterior and septal wall, the left circumflex artery supplies the lateral wall, and the right coronary artery supplies the inferior wall. Perfusion is graded from&#x000a0;0-normal uptake, 1-mildly reduced uptake, 2-moderately reduced uptake, 3-severely reduced uptake, and 4-no uptake. If there is no defect in stress and rest images, it is a normal myocardium (see <bold>Image.</bold> Normal Myocardial Perfusion Scan Showing Location of Segments). If there is a defect in stress images and normal rest images, it is ischemic myocardium. If there is a defect both on rest and stress, it is either a scar or hibernating myocardium. Stress-induced cavity dilation on scan indicates severe and extensive coronary artery disease, either multivessel or left main involved.</p>
      </sec>
      <sec id="article-128620.s4" sec-type="Indications">
        <title>Indications</title>
        <p>
<bold>Diagnosis of Ischemic Heart Disease With Intermediate-risk for CAD and or Risk Stratification of Patients with an Intermediate or High Likelihood of CAD</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>For identification of the extent, severity, and location of myocardial ischemia</p>
          </list-item>
          <list-item>
            <p>Assess the functional significance of intermediate&#x000a0; coronary artery stenosis</p>
          </list-item>
          <list-item>
            <p>Intermediate Duke Treadmill score (<bold>score</bold>&#x000a0;between 4 and -11) on exercise stress test (ETT)</p>
          </list-item>
          <list-item>
            <p>Repeat testing&#x000a0; in patients with a change in their ischemic symptoms</p>
          </list-item>
          <list-item>
            <p>Repeat testing in 1 to 3 years in patients with a high likelihood of coronary artery disease</p>
          </list-item>
          <list-item>
            <p>Severe coronary calcification on CT angiogram with unpredictable ECG</p>
          </list-item>
          <list-item>
            <p>Asymptomatic patients but with high-risk occupations ( such as&#x000a0;firefighters and pilots)</p>
          </list-item>
        </list>
        <p>MPS is contraindicated for the screening of&#x000a0; asymptomatic patients with a low likelihood of ischemic coronary artery disease</p>
        <p>
<bold>Assessment of Interventions and Therapy in Ischemic Heart Disease&#x000a0; </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>To assess patients 3 to 5 years after revascularization (either CABG or Coronary angioplasty) in high-risk asymptomatic patients</p>
          </list-item>
          <list-item>
            <p>Repeat testing to evaluate the therapeutic efficacy in patients with ischemic heart disease</p>
          </list-item>
        </list>
        <p>MPS is contraindicated for routine assessment of patients after coronary angioplasty or CABG</p>
        <p>
<bold>Before Non-cardiac Surgery </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Intermediate-risk surgery or vascular surgery and risk factors with poor functional capacity (&#x0003c;4 METS)<xref ref-type="bibr" rid="article-128620.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>MPS is contraindicated in low-risk, intermediate-risk, or vascular surgery and has a good functional class.</p>
      </sec>
      <sec id="article-128620.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>MPS is contraindicated in pregnant or breastfeeding patients, acute myocardial infarction (&#x0003c;2 days), acute myocarditis, acute pulmonary embolism, acute aortic dissection, acute symptomatic medical illness (such as metastatic cancer), severe symptomatic aortic stenosis, severe pulmonary artery hypertension, high-risk unstable angina, congestive heart failure, severe hypertension (&#x0003e;200/110 mmHg) and sustained cardiac arrhythmias.<xref ref-type="bibr" rid="article-128620.r6">[6]</xref>&#x000a0;MPS is relatively contraindicated in patients with significant left main coronary artery disease, asymptomatic severe aortic stenosis (mean gradient &#x0003e; 40 mmHg, aortic valve area &#x0003c; 1cmsq, aortic jet velocity &#x0003e; 4 m/sec), hypertrophic obstructive cardiomyopathy, or forms of severe left ventricular outflow obstruction, complete heart block.</p>
      </sec>
      <sec id="article-128620.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>The equipment required for a myocardial perfusion scan includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Treadmill machine for exercise</p>
          </list-item>
          <list-item>
            <p>Pharmacologic agents, vasodilators and Ionotropes</p>
          </list-item>
          <list-item>
            <p>The antidote to reverse the effects of vasodilator and inotropes, if required</p>
          </list-item>
          <list-item>
            <p>Radiotracer</p>
          </list-item>
          <list-item>
            <p>Myocardial perfusion gamma scan machine</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-128620.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>Personnel involved in conducting a myocardial perfusion scan include:</p>
        <list list-type="bullet">
          <list-item>
            <p>A nuclear cardiologist or radiologist</p>
          </list-item>
          <list-item>
            <p>Nuclear technologist</p>
          </list-item>
          <list-item>
            <p>Staff nurse</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-128620.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>Patient preparation: Before the test, fast for 3 hours and avoid caffeine-containing foods and drinks for at least 12 hours. Blood pressure medications with antianginal properties (beta-blocker, calcium channel blocker, and nitrates) should be held 12 hours before the procedure.</p>
      </sec>
      <sec id="article-128620.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>
<bold>Stress</bold>
</p>
        <p>There are&#x000a0;2 ways to perform stress testing:</p>
        <list list-type="order">
          <list-item>
            <p>Exercise</p>
          </list-item>
          <list-item>
            <p>Pharmacological&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Exercise</bold>
</p>
        <p>This mode is preferable, as it also informs the functional capacity of the patient. The Bruce protocol is applied for exercise, and the patient walks on a treadmill until 85% of MPHR (Maximum predicted heart rate) is achieved. The achievement of the target MPHR (maximum predicted heart rate) does not indicate that the test should end earlier. The radiotracer was injected as close to peak exercise as possible. Patients should be encouraged to exercise for at least 1 minute after the radiotracer injection. However, exercise should be terminated early if patients start having moderate to severe chest pain, marked shortness of breath, extreme fatigue, ataxia, dizziness, or near-syncope, signs of decreased peripheral perfusion such as cyanosis and pallor, patients are&#x000a0;not able to exercise further, drop in systolic blood pressure of greater than 10 mmHg from baseline, hypertensive response (systolic blood pressure &#x0003e;230 mmHg and/or diastolic pressure&#x0003e;115 mmHg), unable&#x000a0;to monitor the electrocardiogram or systolic blood pressure and in patients with implantable cardioverter defibrillators, when the heart rate achieved is within 20 beats per minute of the lowest heart rate at which therapy (anti-tachycardia pacing or shock) is programmed to be delivered. The recommendation to terminate exercise tests early&#x000a0;on an electrocardiogram basis is excessive ST-segment depression (&#x0003e;2 mm from baseline), ST elevation (&#x0003e;1 mm), sustained supraventricular tachycardia, or ventricular tachycardia, development of&#x000a0;left bundle branch block&#x000a0;or intraventricular conduction delay that cannot be differentiated from ventricular tachycardia.<xref ref-type="bibr" rid="article-128620.r7">[7]</xref></p>
        <p>
<bold>Pharmacologic Agents</bold>
</p>
        <p>Vasodilators: dipyridamole, adenosine, and regadenoson are 3 agents used as vasodilators for MPS. Vasodilator stress is recommended in all patients who are unable to exercise or who are unable to tolerate submaximal exercise. If the patient has a baseline left bundle branch block, a stress test with a vasodilator is preferable to exercise. Vasodilator testing is contraindicated in high-grade AV block patients, patients with a history of severe reactive airway disease, and patients who have consumed caffeinated drinks. The doses for myocardial perfusion scan of vasodilators are dipyridamole 0.56 mg/kg, adenosine 140 mcg/kg/min, and regadenoson 0.4 mg. Intravenous adenosine continuous infusion starts at 140 mcg/kg/min. A radiotracer injection should be given at 3 minutes, and then adenosine infusion continues for the next 3 minutes. A single intravenous dose of 0.4 mg is given for regadenoson, followed by a 5 ml normal saline flush, and radiotracer is given 10 to 20 seconds after the normal saline flush. For dipyridamole, continuous infusion is given at 0.56 mg/kg for 4 minutes, then stops, and radiotracer should be given after 3 to 5 minutes of stoppage of dipyridamole infusion. To reverse the effects of vasodilators, aminophylline can be given 50 to 250 mg intravenously.<xref ref-type="bibr" rid="article-128620.r8">[8]</xref></p>
        <p>Inotropes are indicated in patients who have contraindications to exercise and vasodilators. Dobutamine is a commonly used inotrope for MPS. Dobutamine infusion starts at 5 to 10 mcg /kg/min and increases every 2 mins until MPHR(Maximum predicted heart rate) is achieved. Once MPHR (maximum predicted heart rate) is achieved, a radiotracer is injected, and then dobutamine should be continued for the next minute. Dobutamine is contraindicated in patients with severe hypertension, unstable arrhythmia, and severe left main disease.</p>
        <p>
<bold>Radiotracer</bold>
</p>
        <p>There are&#x000a0;2 commonly used radiotracers for MPS.</p>
        <list list-type="order">
          <list-item>
            <p>Thallium-201</p>
          </list-item>
          <list-item>
            <p>Technetium&#x02013;99</p>
          </list-item>
        </list>
        <p>Thallium-201&#x000a0;is a monovalent cation, a property similar to potassium. It has a half-life&#x000a0;of 73 hours and emits 80 keV photons. Its peak myocardial concentration is achieved in 5 minutes and has the property of rapid clearance from the intravascular compartment. The differential washout-clearance of thallium 201 is more rapid than normal myocardium. As hyperinsulinemia stated, fasting is essential to reduce blood concentration and slow the distribution of thallium 201. Thallium should be injected at peak stress, and images should be taken 10 to 15 mins of injection. Rest images after 4 hours of stress image.<xref ref-type="bibr" rid="article-128620.r9">[9]</xref></p>
        <p>Advantages of thallium-201:</p>
        <list list-type="order">
          <list-item>
            <p>Its redistribution property allows single-injection studies and viability assessment.</p>
          </list-item>
          <list-item>
            <p>It is less expensive.</p>
          </list-item>
          <list-item>
            <p>It has less abdominal and hepatic uptake during exercise</p>
          </list-item>
        </list>
        <p>Technetium&#x02013;99&#x000a0;has a half-life of 6 hrs and emits 140 keV photons. Limited washout occurs with technetium&#x02013;99 tracers bound by mitochondria, so imaging can commence later and be repeated. Rest images are obtained after 15 to 45 minutes of stress.<xref ref-type="bibr" rid="article-128620.r10">[10]</xref></p>
        <p>Advantages of technetium&#x02013;99:</p>
        <list list-type="order">
          <list-item>
            <p>It has a shorter half-life, which allows for a higher dose, resulting in better count statistics</p>
          </list-item>
          <list-item>
            <p>It has less&#x000a0;radiation exposure and attenuation effects</p>
          </list-item>
          <list-item>
            <p>It has higher energy levels, which allow improved resolution.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-128620.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Complications from a myocardial perfusion scan are rare. A few possible complications are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Radiation exposure (low radiation exposure)<xref ref-type="bibr" rid="article-128620.r11">[11]</xref><xref ref-type="bibr" rid="article-128620.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Myocardial infarction (rare)</p>
          </list-item>
          <list-item>
            <p>Arrhythmia (rare)</p>
          </list-item>
          <list-item>
            <p>Non-ischemic chest pain, especially from dipyridamole and adenosine</p>
          </list-item>
          <list-item>
            <p>Wheeze</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-128620.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Myocardial perfusion scan plays a vital role in diagnosing ischemic heart disease and assessing the effectiveness of medical management in patients with known coronary artery disease. It is a useful non-invasive test to assess the blood supply of the myocardium. It also helps in preoperative cardiovascular risk assessment of patients with poor functional class and intermediate-risk surgery. The risk of perioperative cardiovascular risk is directly proportional to the severity of perfusion defect on myocardial perfusion scan.</p>
      </sec>
      <sec id="article-128620.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>A myocardial perfusion scan requires an interprofessional team that includes a nuclear cardiologist or radiologist, a staff nurse, and a nuclear technologist. Proper history taking and a physical examination before the procedure are essential. Which stress mode should be selected depends upon the patient's functional class and comorbidities. Giving a radiotracer and performing a scan at the appropriate time is important to get the best results.</p>
      </sec>
      <sec id="article-128620.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=128620&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=128620">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/128620/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=128620">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-128620.s14">
        <fig id="article-128620.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Normal Myocardial Perfusion Scan Showing Location of Segments Contributed by Ghufran Adnan</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MPS__Normal" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-128620.s15">
        <title>References</title>
        <ref id="article-128620.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Russell</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Zaret</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>Nuclear cardiology: present and future.</article-title>
            <source>Curr Probl Cardiol</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>9</issue>
            <fpage>557</fpage>
            <page-range>557-629</page-range>
            <pub-id pub-id-type="pmid">16935694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128620.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elfigih</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Henein</surname>
                <given-names>MY</given-names>
              </name>
            </person-group>
            <article-title>Non-invasive imaging in detecting myocardial viability: Myocardial function versus perfusion.</article-title>
            <source>Int J Cardiol Heart Vasc</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>5</volume>
            <fpage>51</fpage>
            <page-range>51-56</page-range>
            <pub-id pub-id-type="pmid">28785612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128620.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sethi</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Namgyal</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Sehgal</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Accuracy of Stress Myocardial Perfusion Imaging in Indian Diabetic Patients: A Single Centre Experience.</article-title>
            <source>Indian J Nucl Med</source>
            <year>2017</year>
            <season>Jul-Sep</season>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>177</fpage>
            <page-range>177-183</page-range>
            <pub-id pub-id-type="pmid">28680199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128620.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fathala</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Myocardial perfusion scintigraphy: techniques, interpretation, indications and reporting.</article-title>
            <source>Ann Saudi Med</source>
            <year>2011</year>
            <season>Nov-Dec</season>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>625</fpage>
            <page-range>625-34</page-range>
            <pub-id pub-id-type="pmid">22048510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128620.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hashimoto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nakahara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kitamura</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kasamatsu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kubo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Preoperative risk stratification with myocardial perfusion imaging in intermediate and low-risk non-cardiac surgery.</article-title>
            <source>Circ J</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>71</volume>
            <issue>9</issue>
            <fpage>1395</fpage>
            <page-range>1395-400</page-range>
            <pub-id pub-id-type="pmid">17721017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128620.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baumgartner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bermejo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chambers</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Evangelista</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Pellikka</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Qui&#x000f1;ones</surname>
                <given-names>M</given-names>
              </name>
              <collab>American Society of Echocardiography</collab>
              <collab>European Association of Echocardiography</collab>
            </person-group>
            <article-title>Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice.</article-title>
            <source>J Am Soc Echocardiogr</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-23; quiz 101-2</page-range>
            <pub-id pub-id-type="pmid">19130998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128620.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheike</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nylander</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Exercise testing and myocardial perfusion scintigraphy in primary care patients with chest pain of new onset.</article-title>
            <source>Scand J Prim Health Care</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>117</fpage>
            <page-range>117-22</page-range>
            <pub-id pub-id-type="pmid">17497490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128620.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cury</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Kitt</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Feaheny</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Akin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Regadenoson-stress myocardial CT perfusion and single-photon emission CT: rationale, design, and acquisition methods of a prospective, multicenter, multivendor comparison.</article-title>
            <source>J Cardiovasc Comput Tomogr</source>
            <year>2014</year>
            <season>Jan-Feb</season>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-12</page-range>
            <pub-id pub-id-type="pmid">24314823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128620.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beller</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Myocardial perfusion imaging with thallium-201.</article-title>
            <source>J Nucl Med</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>674</fpage>
            <page-range>674-80</page-range>
            <pub-id pub-id-type="pmid">8151393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128620.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maddahi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kiat</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Van Train</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Prigent</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Alazraki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>DePuey</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Nichols</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Berman</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.</article-title>
            <source>Am J Cardiol</source>
            <year>1990</year>
            <month>Oct</month>
            <day>16</day>
            <volume>66</volume>
            <issue>13</issue>
            <fpage>55E</fpage>
            <page-range>55E-62E</page-range>
            <pub-id pub-id-type="pmid">2145748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128620.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Einstein</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Effects of radiation exposure from cardiac imaging: how good are the data?</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2012</year>
            <month>Feb</month>
            <day>07</day>
            <volume>59</volume>
            <issue>6</issue>
            <fpage>553</fpage>
            <page-range>553-65</page-range>
            <pub-id pub-id-type="pmid">22300689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128620.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berrington de Gonzalez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Smith-Bindman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McAreavey</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Myocardial perfusion scans: projected population cancer risks from current levels of use in the United States.</article-title>
            <source>Circulation</source>
            <year>2010</year>
            <month>Dec</month>
            <day>07</day>
            <volume>122</volume>
            <issue>23</issue>
            <fpage>2403</fpage>
            <page-range>2403-10</page-range>
            <pub-id pub-id-type="pmid">21098448</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
